Home › Heart Failure › Mississippi
Heart Failure clinical trials in Mississippi
7 studies for Heart Failure are looking for participants at sites in Mississippi.
Cities in Mississippi
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- Jackson Heart Clinic, P.A., Jackson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06424288Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Research Site, Jackson
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 11, 2026 · NCT06307652A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- Tupelo, MS Investigative Site 10100, Tupelo
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT06008197A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
- Local Institution - 164, Jackson
RecruitingPhase 2
Ages 30 to 84 · All sexes · Updated Aug 31, 2026 · NCT07795814Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
- University of Mississippi Medical Center, Jackson
Recruiting
Ages 21 and older · All sexes · Updated Aug 25, 2026 · NCT05677100A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Cardiology Associates Research, Llc, Tupelo
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Hawthorne Health, Diamondhead
- Univ of Mississippi Med Center, Jackson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT07567001From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.